KA
Kabeer Aziz
Partner at Adjuvant Capital
New York, New York
Overview
Kabeer Aziz is a Co-founder and Partner at Adjuvant Capital in New York, with a background in investment and finance, having worked at Global Health Investment Fund and Metalmark Capital. He has successfully invested in companies like Minervax, LimmaTech Biologics, and Pulmocide, contributing to the growth of the healthcare and biotech sectors.
Aziz's career highlights include his role as a Partner at Adjuvant Capital, where he focuses on investing in various sectors such as diagnostics, medical devices, pharmaceuticals, and biotech, and his previous experience at Global Health Investment Fund, Metalmark Capital, and Greenhill & Co. as an Analyst.
Work Experience
Partner
2018 - Current
Leading life sciences investment fund focused on global public health
Adjuvant Capital is a life sciences investment firm focused on global health.
Director
2019
AN2 Therapeutics focuses on modern biomedical and drug development expertise to provide transformational medicines.
Raised $162,000,000.00 from Bill & Melinda Gates Foundation and Bill & Melinda Gates Foundation.
Director
2020
Director
2020
Director
2021
Board Observer
2022
Director
2024
ChromaCode is a molecular diagnostics company focusing on bioinformatics.
Raised $93,967,513.00 from Global Brain Corporation.
Director
2021 - 2023
Board Observer
2018 - 2020
Senior Associate
2015 - 2018
Impact investing to finance global health research & development